Molecular Insight Pharmaceuticals molecularinsight.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Molecular Insight is a clinical-stage biopharmaceutical company focused on the critical unmet diagnostic and therapeutic needs of the prostate cancer patient. The Company is targeting the development of a small-molecule chemistry platform to improve detection of primary and metastatic prostate cancer and to provide a novel systemic radiotherapy for relapsed and metastatic prostate cancer. In January 2013, Molecular Insight Pharmaceuticals was acquired by Progenics Pharmaceuticals. The valuation...Show all

Molecular Insight is a clinical-stage biopharmaceutical company focused on the critical unmet diagnostic and therapeutic needs of the prostate cancer patient. The Company is targeting the development of a small-molecule chemistry platform to improve ...Show all

Company (Acquired)

Phone: 617-492-5554

Fax:

160 Second Street

Cambridge, 02142
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Molecular Insight Pharmaceuticals $100.1M Jan 23, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Molecular Insight Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Organ protection in psma-targeted radionuclide therapy of prostate cancer Sep 04, 2015 May 01, 2018 Patent
Heterodimers of glutamic acid Oct 28, 2016 Jan 30, 2018 Patent
Psma-targeted dendrimers Dec 06, 2011 Jun 27, 2017 Patent
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof Jan 30, 2015 Sep 06, 2016 Patent
Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereof Jul 29, 2014 Feb 24, 2015 Patent
See all 15 patents